Program

The program of the 16th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance is being developed. Below please find the preliminary program.eak

WEDNESDAY, MAY 30, 2018

10:00

Opening of the Meetings

10:15

The role of the human microbiome on HIV infection
Roger Paredes, MD, PhD, Irsi Caixa Foundation, Barcelona, Spain

 Session 1 - The future of the epidemic in Europe
10:45

The HIV epidemic in CEE countries
Oana Sandulescu, MD, PhD, Carol Davila Univ Med Pharm, Bucharest, Romania

11:15

HIV transmission in the migrant population
Dimitrios Paraskevis, PhD, National and Kapodistrian University of Athens Medical School, Athens, Greece 

11:45

How would the epidemic evolve in the future?
David van de Vijver, PharmD, PhD, Erasmus Medical Center, Rotterdam, the Netherlands

12:15

Discussion

12:45Lunch
  
 Session 2
13:45Evolution of wildtype virus
14:15 - 14:45Abstract-driven presentations
15:00Coffee Break
  
 Session 3 - The roll-out of PrEP
15:30

The current status of PrEP in Europe

16:00

Influence of resistance in the future
Richard Harrigan, MD, PhD, BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

16:30

Risk compensation in STDs

Jade Ghosn, MD, Hopital Hotel Dieu, Lyon, France

17:00Discussion
  
17:30Guided poster tour 1: Epidemiology/transmission
  
18:00Welcome Reception & Poster Viewing

THURSDAY, MAY 31, 2018

 Session 4 - Clinical Management of PLWH
8:30T.B.A.
9:00 - 10:00Abstract-driven presentations
10:15Discussion
  
10:30Guided poster tour 2: Clinical Management of PLWH
  
11:00Coffee Break + Poster Viewing
  
12:00T.B.A.
  
13:00Lunch
  
 Session 5 - Round Table Discussion: Bringing the next generation sequencing to the clinic

14:00 

15:00

Bringing the next generation sequencing to the clinic
Marc Noguera-Julian, PhD, Fundacio irsiCaixa, Barcelona, Spain
Roundtable discussion

  
15:30Coffee Break
  
 Session 6 - Management of Viral Hepatitis
16:00Management of Hepatitis C therapy failures - Virological perspective
Francesca Ceccherini - Silbersteini, PhD, University of Rome "Tor Vergata", Italy
16:30

Management of Hepatitis C therapy failures - Clinical perspective
Sanjay Bhagani, BSc FRCP, Royal Free Hospital, London, United Kingdom

17:00Acute Hepatitis A to E, Diagnosis and Management
17:30Discussion
18:00End of Program day 2

FRIDAY, JUNE 1, 2018

 Session 7 - Industry presentation - Pipeline
8:30 - 9:30Company slots
9:45Discussion
  
10:15Guided poster tour 3: Hepatitis-related abstracts
  
10:45Coffee Break
  
 Session 8 - Therapy strategies in 2019 and beyond
11:30Reduced drug regimens
Andrea de Luca, MD, University of Siena, Italy
12:00

What is the place of monoclonal antibodies in the clinic
Julià Blanco, PhD, IrsiCaixa Foundation, Barcelona, Spain

12:30Discussion
13:00Closure of the workshop
 Invited Speakers